Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Advanced Drug Delivery Reviews, 12/18/07
Sherman, M.R. - Hyperuricemia results from an imbalance between the rates of production and excretion of uric acid. Longstanding hyperuricemia can lead to gout, which is characterized by the deposition of monosodium urate monohydrate crystals in the joints and periarticular structures. Because such deposits are resolved very slowly by lowering plasma urate with available drugs or other measures, the symptoms of gout may become chronic. Persistent hyperuricemia may also increase the risk of renal and cardiovascular diseases
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
A clinical picture of chronic polyarticular tophaceous gout
Rheumatology International, 12/20/09
Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


